GlassScriptPhysician profile
Adam Leyendecker
NPI 1861097206
$1,783.98
in general payments reported to CMS, 2019-2025
11 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,227 · 2024: $406 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $308.79 | 2023-2024 | Auvelity |
| Alkermes, INC. | $243.32 | 2023-2025 | Lybalvi, Vivitrol, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $233.66 | 2023-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Supernus Pharmaceuticals, INC. | $196.80 | 2023-2024 | Qelbree, Qelbree |
| Abbvie INC. | $189.80 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $184.30 | 2023 | |
| Janssen Pharmaceuticals, INC | $170.03 | 2023 | Invega Sustenna, Invega Trinza |
| Indivior INC. | $115.46 | 2023-2024 | Sublocade |
| Uswm, LLC | $72.62 | 2023 | Lucemyra, Zimhi |
| Braeburn INC. | $49.54 | 2024-2025 | Brixadi |
| Hologic Sales and Service, LLC | $19.66 | 2023 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Leyendecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.